Literature DB >> 24762928

Use of laboratory reports as predictors of West Nile virus disease cases, Texas, 2008-2012.

S J Yendell1, J Taylor2, B J Biggerstaff1, L Tabony2, J E Staples1, M Fischer1.   

Abstract

We evaluated laboratory reports as early indicators of West Nile virus (WNV) disease cases in Texas. We compared WNV laboratory results in the National Electronic Disease Surveillance System Base System (NBS) to WNV disease cases reported to the state health department from 2008 to 2012. We calculated sensitivity and positive predictive value (PPV) of NBS reports, estimated the number of disease cases expected per laboratory report, and determined lead and lag times. The sensitivity and PPV of NBS laboratory reports were 86% and 77%, respectively. For every 10 positive laboratory reports, we expect 9·0 (95% confidence interval 8·9-9·2) reported disease cases. Laboratory reports preceded case reports with a lead time of 7 days. Electronic laboratory reports provided longer lead times than manually entered reports (P < 0·01). NBS laboratory reports are useful estimates of future reported WNV disease cases and may provide timely information for planning public health interventions.

Entities:  

Mesh:

Year:  2014        PMID: 24762928      PMCID: PMC9206794          DOI: 10.1017/S0950268814000909

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  14 in total

1.  Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with conventional methods.

Authors:  P Effler; M Ching-Lee; A Bogard; M C Ieong; T Nekomoto; D Jernigan
Journal:  JAMA       Date:  1999-11-17       Impact factor: 56.272

Review 2.  Molecular amplification assays for the detection of flaviviruses.

Authors:  Robert S Lanciotti
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

3.  State electronic disease surveillance systems --- United States, 2007 and 2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-10-21       Impact factor: 17.586

4.  Benefits and barriers to electronic laboratory results reporting for notifiable diseases: the New York City Department of Health and Mental Hygiene experience.

Authors:  Trang Quyen Nguyen; Lorna Thorpe; Hadi A Makki; Farzad Mostashari
Journal:  Am J Public Health       Date:  2007-04-05       Impact factor: 9.308

5.  Unpredictable and difficult to control--the adolescence of West Nile virus.

Authors:  Lyle R Petersen; Marc Fischer
Journal:  N Engl J Med       Date:  2012-09-26       Impact factor: 91.245

6.  Disease reporting from an automated laboratory-based reporting system to a state health department via local county health departments.

Authors:  H D Backer; S R Bissell; D J Vugia
Journal:  Public Health Rep       Date:  2001 May-Jun       Impact factor: 2.792

7.  Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections.

Authors:  D A Martin; D A Muth; T Brown; A J Johnson; N Karabatsos; J T Roehrig
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

8.  Laboratory testing practices for West Nile virus in the United States.

Authors:  Kristen B Janusz; Jennifer A Lehman; Amanda J Panella; Marc Fischer; Erin Staples
Journal:  Vector Borne Zoonotic Dis       Date:  2010-09-17       Impact factor: 2.133

9.  Clinicopathologic study and laboratory diagnosis of 23 cases with West Nile virus encephalomyelitis.

Authors:  Jeannette Guarner; Wun-Ju Shieh; Steve Hunter; Christopher D Paddock; Timothy Morken; Grant L Campbell; Anthony A Marfin; Sherif R Zaki
Journal:  Hum Pathol       Date:  2004-08       Impact factor: 3.466

10.  West Nile virus and other arboviral diseases--United States, 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-06-28       Impact factor: 17.586

View more
  1 in total

1.  Use of Testing for West Nile Virus and Other Arboviruses.

Authors:  Jakapat Vanichanan; Lucrecia Salazar; Susan H Wootton; Elizabeth Aguilera; Melissa N Garcia; Kristy O Murray; Rodrigo Hasbun
Journal:  Emerg Infect Dis       Date:  2016-09       Impact factor: 6.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.